How were AMBI's earnings last quarter?

AMBI (NASDAQ:AMBI) posted its quarterly earnings data on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.47) by $0.03. The biopharmaceutical company had revenue of $0.03 million for the quarter, compared to the consensus estimate of $3.50 million.

What ETF holds AMBI's stock?

VanEck Environmental Services ETF holds 190,775 shares of AMBI stock, representing 2.15% of its portfolio.

What other stocks do shareholders of AMBI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AMBI investors own include Alexion Pharmaceuticals (ALXN) , Amarin (AMRN) , Broadcom (BRCM) , Cytokinetics (CYTK) , Delta Air Lines (DAL) , Fortress Biotech (FBIO) , FireEye (FEYE) , Five Prime Therapeutics (FPRX) , Glu Mobile (GLUU) and Halozyme Therapeutics (HALO) .

NASDAQ:AMBI

AMBI (AMBI) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free AMBI Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $4.44
▼
$5.04
50-Day Range: N/A
52-Week Range: N/A

Volume: 3,472 shs
Average Volume: 5,547 shs
Market Capitalization: $254.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Headlines Social Media

Get AMBI alerts:

Ad American Alternative

Your Money is Not Safe

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

About AMBI Stock (NASDAQ:AMBI)

Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

Ad American Alternative

Your Money is Not Safe

CLICK HERE TO GET YOUR GUIDE NOW

AMBI Stock News Headlines

April 16, 2024 | finance.yahoo.com

P&G Appoints Neal Reed as Senior Vice President and Managing Director, P&G Australia and New Zealand

April 13, 2024 | msn.com

MP: Minor Girl Abducted, Sold Off For ₹90K In Alirajpur; 3 Booked

April 17, 2024 | American Alternative (Ad)

Your Money is Not Safe

April 12, 2024 | ca.news.yahoo.com

These 74 robotics companies are hiring

April 11, 2024 | msn.com

Jaanmoni ki Shaap, Jinto-Gabri's dirty game to Mohanlal's swag: Bigg Boss Malayalam 6 Week 4 review

April 9, 2024 | msn.com

East Bay EDA Honors Two Alameda Businesses for Innovation

April 8, 2024 | msn.com

Ambidextrous San Diego man shares the benefits of 'Symmetrical Living'

April 4, 2024 | msn.com

Bambi: The Reckoning teaser is stuff children's horror dreams are made of

April 17, 2024 | American Alternative (Ad)

Your Money is Not Safe

April 3, 2024 | au.finance.yahoo.com

Tide evo, a Revolutionary New Tile Form a Decade in the Making, is Now Available Exclusively in Colorado

April 3, 2024 | msn.com

WB projects only 1.8 percent growth for Pakistan

March 29, 2024 | sg.style.yahoo.com

Sandy Wu's cafe attacked by two men

March 29, 2024 | msn.com

Taiwanese Star Sandy Wu’s Cafe Targeted With Vandalism Attack

March 25, 2024 | msn.com

Hollywood And Fans Are Already Buzzing Over Christopher Nolan's Next Film

March 22, 2024 | msn.com

How Hallmark Favorite Tyler Hynes Is Celebrating Women — and His Mom! — with New Movie “Shifting Gears” (Exclusive)

March 21, 2024 | cbsnews.com

Businesswomen connect and share secrets to success in Harlem

March 21, 2024 | msn.com

Feel Like You Can Be Both Poly *and* Monogamous? You Might Be Ambiamorous

March 20, 2024 | msn.com

Quantum Tornado Unveils Insights into Black Hole Mysteries

March 18, 2024 | msn.com

14 Best Drugstore Vitamin C Serums for Bright Skin, According to Experts

March 15, 2024 | msn.com

Navigating the Cosmos

March 15, 2024 | msn.com

CBD Punjab leads charge as Maryam Nawaz green lights Nawaz Sharif IT City

March 8, 2024 | stockhouse.com

A Leap Forward in Laundry: Tide launches a revolutionary new tile form to transform laundry day

March 8, 2024 | msn.com

The booming business of tiny: Ambi Parameswaran, on how small packs got everywhere

March 6, 2024 | msn.com

Empowering Women Drivers in Pakistan

March 6, 2024 | msn.com

PCB chief advocates merit and unity for Pakistan cricket's ascendancy

March 5, 2024 | msn.com

Rani: The Real Story On OTT: All You Need To Know About Release Date, Platform & Cast

February 26, 2024 | msn.com

Taita Taveta Deputy Speaker released on Sh1 million bond

See More Headlines

Receive AMBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/06/2014
Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Industrial Products
Industry: Sanitary services
Sub-Industry: N/A
Current Symbol: NASDAQ:AMBI
CUSIP: N/A
CIK: 1131543
Web: www.hpxcorp.com
Phone: +1-858-3342100
Fax: N/A
Employees: 5,041
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 1.33
Current Ratio: 2.29
Quick Ratio: 2.23

Sales & Book Value

Annual Sales: $326.33 million
Price / Sales: 0.80
Cash Flow: $7.26 per share
Price / Cash Flow: 0.65
Book Value: $10.21 per share
Price / Book: 0.46

Miscellaneous

Outstanding Shares: 55,410,000
Free Float: 26,597,000
Market Cap: $261.54 million
Optionable: Not Optionable
Beta: 0.61

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Competitors

View All Competitors

AMBI Stock Analysis - Frequently Asked Questions

How were AMBI's earnings last quarter?: AMBI (NASDAQ:AMBI) posted its quarterly earnings data on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.47) by $0.03. The biopharmaceutical company had revenue of $0.03 million for the quarter, compared to the consensus estimate of $3.50 million.
What ETF holds AMBI's stock?: VanEck Environmental Services ETF holds 190,775 shares of AMBI stock, representing 2.15% of its portfolio.
What other stocks do shareholders of AMBI own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AMBI investors own include Alexion Pharmaceuticals (ALXN), Amarin (AMRN), Broadcom (BRCM), Cytokinetics (CYTK), Delta Air Lines (DAL), Fortress Biotech (FBIO), FireEye (FEYE), Five Prime Therapeutics (FPRX), Glu Mobile (GLUU) and Halozyme Therapeutics (HALO).

This page (NASDAQ:AMBI) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AMBI (AMBI) Stock Price, News & Analysis

About AMBI Stock (NASDAQ:AMBI)

AMBI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

AMBI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info